Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - porcine parvo virus - inactivated; thiomersal - misc. vaccines or anti sera - porcine parvo virus - inactivated vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - parvovirus

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - inactivated viral and inactivated bacterial vaccines - pigs - for active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with pcv2.for active immunisation of pigs over the age of 3 weeks against mycoplasma hyopneumoniae to reduce lung lesions caused by infection with m. hyopneumoniae.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - insulin isophane porcine; insulin soluble porcine - suspension for injection - 70unit/1ml ; 30unit/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - insulin isophane porcine; insulin soluble porcine - suspension for injection - 70unit/1ml ; 30unit/1ml

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - porcine parvovirus (inactivated) - porcine parvovirus (inactivated) 0 vaccine - vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zamira life sciences pty ltd - porcine somatotropin = pst; porcine somatotropin = pst - parenteral liquid/solution/suspension - porcine somatotropin = pst hormone-somatotropin active 10.0 mg/ml; porcine somatotropin = pst hormone-somatotropin active 5.0 mg/ml - nutrition & metabolism - pigs | boar | gilt | piglet | sow | swine - improve feed efficiency | promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios calier s.a. - porcine follicle stimulant hormone 500 iu/dose; porcine luteinizing hormone 500 iu/dose - powder and solvent for solution for injection - porcine follitropine (fshp) 500 iu; porcine lutropine hormone (lhp) 500 iu - gonadotropins, combinations - cattle

European Union - English - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologicals for suidae - pigs (for fattening) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d.active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - porcine epidemic diarrhea virus (pedv) vaccine (vet.) - solution for injection (im) - formulation: each dose contains: porcine epidemic diarrhea replicon particle............>5 x 10rp rp-relative potency

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - quinupristin (unii: 23ow28rs7p) (quinupristin - unii:23ow28rs7p), dalfopristin (unii: r9m4fje48e) (dalfopristin - unii:r9m4fje48e) - quinupristin 150 mg in 5 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of synercid and other antibacterial drugs, synercid should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. synercid is indicated in adults for the treatment of the following infections when caused by susceptible strains of the designated microorganisms. complicated skin and skin structure infections caused by staphylococcus aureus (methicillin susceptible ) or streptococcus pyogenes . (see clinical studies. ) synercid is contraindicated in patients with known hypersensitivity to synercid , or with prior hypersensitivity to other streptogramins (e.g. , pristinamycin or virginiamycin).